Search research articles
Contact Us
Filters
Showing results (131-140 of 136) with videos related to
Page
of 14
Sort By:
You have reached the last page of results.
This site can display upto 136 results.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
September 15, 2001
Characterization of a mouse model for thrombomodulin deficiency
H Weiler, V Lindner, B Kerlin, et al.
Thrombosis and Haemostasis
|
May 3, 2013
Parenteral anticoagulants in heart disease: current status and perspectives (Section II). Position paper of the ESC Working Group on Thrombosis-Task Force on Anticoagulants in Heart Disease
R De Caterina, S Husted, L Wallentin, et al.
Thrombosis Research
|
June 30, 2016
D-dimer levels and recurrence in patients with unprovoked VTE and a negative qualitative D-dimer test after treatment
C Kearon, S Parpia, F A Spencer, et al.
Thrombosis Research
|
November 17, 2019
Edoxaban for treatment of venous thromboembolism in patient groups with different types of cancer: Results from the Hokusai VTE Cancer study
F I Mulder, N van Es, N Kraaijpoel, et al.
Thrombosis Research
|
March 11, 2020
Corrigendum to "Edoxaban for treatment of venous thromboembolism in patient groups with different types of cancer: Results from the Hokusai VTE Cancer study" [Thromb. Res. vol. 185, January 2020, pages 13-19]
F I Mulder, N van Es, N Kraaijpoel, et al.
Journal of Thrombosis and Haemostasis : JTH
|
April 22, 2004
Comparison of 1 month with 3 months of anticoagulation for a first episode of venous thromboembolism associated with a transient risk factor
C Kearon, J S Ginsberg, D R Anderson, et al.
Page
of 14
Search research articles
Search
Showing results (131-140 of 136) with videos related to
Sort By:
Page
of 14
You have reached the last page of results.
This site can display upto 136 results.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
September 15, 2001
Characterization of a mouse model for thrombomodulin deficiency
H Weiler, V Lindner, B Kerlin, et al.
Thrombosis and Haemostasis
|
May 3, 2013
Parenteral anticoagulants in heart disease: current status and perspectives (Section II). Position paper of the ESC Working Group on Thrombosis-Task Force on Anticoagulants in Heart Disease
R De Caterina, S Husted, L Wallentin, et al.
Thrombosis Research
|
June 30, 2016
D-dimer levels and recurrence in patients with unprovoked VTE and a negative qualitative D-dimer test after treatment
C Kearon, S Parpia, F A Spencer, et al.
Thrombosis Research
|
November 17, 2019
Edoxaban for treatment of venous thromboembolism in patient groups with different types of cancer: Results from the Hokusai VTE Cancer study
F I Mulder, N van Es, N Kraaijpoel, et al.
Thrombosis Research
|
March 11, 2020
Corrigendum to "Edoxaban for treatment of venous thromboembolism in patient groups with different types of cancer: Results from the Hokusai VTE Cancer study" [Thromb. Res. vol. 185, January 2020, pages 13-19]
F I Mulder, N van Es, N Kraaijpoel, et al.
Journal of Thrombosis and Haemostasis : JTH
|
April 22, 2004
Comparison of 1 month with 3 months of anticoagulation for a first episode of venous thromboembolism associated with a transient risk factor
C Kearon, J S Ginsberg, D R Anderson, et al.
Page
of 14